Nordic Enterprises See SDN as Key to Network Agility, Working from Home
5.7.2021 11:00:00 EEST | Business Wire | Press release
Enterprises in the Nordics are expanding their adoption of software-defined networking technology to become more agile and flexible while enabling employees to more easily work from home, according to a new report published today by Information Services Group (ISG) (Nasdaq: III), a leading global technology research and advisory firm.
The 2021 ISG Provider Lens™ Network – Software Defined Solutions and Services Report for the Nordics finds enterprises in the region looking to SDN-related technologies and service providers to help them with challenges related to the flexibility, speed and collaboration they need to better serve their employees and their increasingly mobile customers.
“Nordic enterprises are looking to SDN and its service providers to increase their network agility, flexibility and competitiveness while enabling remote working and better business continuity,” said Jan Erik Aase, partner and global leader, ISG Provider Lens Research. “This new need for enterprise agility goes beyond the abilities of traditional networks in a constantly changing competitive environment.”
The report also sees enterprises in the region embracing SD-WAN to enable remote working. While WAN architecture at enterprises has created backhaul challenges, that architecture is evolving to support more connectivity choices. Vendors are enabling enterprises to use a variety of transport options actively or on standby.
In addition, Nordic enterprises are moving toward more automation and analytics. Enterprises are increasingly embracing the concept of the network as code, where changes in the network infrastructure can be handled through code changes. Service providers are leveraging automation tools and allowing visibility into the cloud, the data center, and the WAN. Nordic enterprises see SD-WAN as a way to drive automation, reduce reliance on network hardware and consolidate network functionality.
Nordic enterprises are also seeking end-to-end connectivity to analyze data at the edge, including data generated by Internet of Things (IoT) devices, the report says. Service providers and system integrators are exploring ways to bring new capabilities to Wi-Fi 6, long-term evolution (LTE) and fifth-generation (5G) networks. They are also looking to assist customers with large public 5G rollouts, with some spectrum potentially allocated for enterprises.
New SDN-related technologies will pave the way for the industrial IoT to scale up and for edge computing to grow further, the report adds. However, a more inclusive network ecosystem is needed for the cloud, which is evolving into a holistic web of network technologies that include components of SDN such as WAN, LAN and Wi-Fi 6 management.
The report also sees changes in network practices driven in part by the move in the Nordics to the cloud and to the software-as-a-service model. Enterprises there have been seeing more internet-based traffic, which has led them to consider new ways to look at connectivity. Enterprises are moving away from a conventional hub-and-spoke networking model and considering instead an any-to-any connectivity model that supports more cloud-oriented traffic patterns.
The 2021 ISG Provider Lens™ Network – Software Defined Solutions and Services Report for the Nordics evaluates the capabilities of 55 providers across six quadrants: Managed (SD) WAN Services, SDN Transformation Services (Consulting and Implementation), SD-WAN Equipment and Service Suppliers (DIY), Technology and Service Suppliers (Core – 4G/5G), Edge Technology and Services, and Enterprise 5G Solutions.
The report names Orange Business Services as a leader in five quadrants and BT, Cisco, Deutsche Telekom, HCL, IBM, Tech Mahindra and Wipro as leaders in four. Ericsson, HPE Aruba and Nuage Networks are named leaders in three quadrants, and Infosys, TCS, Telenor, Telia, Verizon and VMware are named leaders in two. Citrix, Juniper Networks, Nokia Networks and Versa Networks are named leaders in one quadrant.
In addition, Tech Mahindra, Verizon and Wipro were named Rising Stars—companies with “promising portfolios” and “high future potential” by ISG’s definition—in two quadrants. GTT and Infosys were named Rising Stars in one quadrant each.
The 2021 ISG Provider Lens™ Network – Software Defined Solutions and Services Report for the Nordics is available to subscribers or for one-time purchase on this webpage.
About ISG Provider Lens™ Research
The ISG Provider Lens™ Quadrant research series is the only service provider evaluation of its kind to combine empirical, data-driven research and market analysis with the real-world experience and observations of ISG's global advisory team. Enterprises will find a wealth of detailed data and market analysis to help guide their selection of appropriate sourcing partners, while ISG advisors use the reports to validate their own market knowledge and make recommendations to ISG's enterprise clients. The research currently covers providers offering their services globally, across Europe, as well as in the U.S., Germany, Switzerland, the U.K., France, the Nordics, Brazil and Australia/New Zealand, with additional markets to be added in the future. For more information about ISG Provider Lens research, please visit this webpage.
A companion research series, the ISG Provider Lens Archetype reports, offer a first-of-its-kind evaluation of providers from the perspective of specific buyer types.
About ISG
ISG (Information Services Group) (Nasdaq: III) is a leading global technology research and advisory firm. A trusted business partner to more than 700 clients, including more than 75 of the world’s top 100 enterprises, ISG is committed to helping corporations, public sector organizations, and service and technology providers achieve operational excellence and faster growth. The firm specializes in digital transformation services, including automation, cloud and data analytics; sourcing advisory; managed governance and risk services; network carrier services; strategy and operations design; change management; market intelligence and technology research and analysis. Founded in 2006, and based in Stamford, Conn., ISG employs more than 1,300 digital-ready professionals operating in more than 20 countries—a global team known for its innovative thinking, market influence, deep industry and technology expertise, and world-class research and analytical capabilities based on the industry’s most comprehensive marketplace data. For more information, visit www.isg-one.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210705005021/en/
Contact information
Will Thoretz, ISG
+1 203 517 3119
will.thoretz@isg-one.com
Erik Arvidson, Matter Communications for ISG
+1 617 755 2985
isg@matternow.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Positive CHMP Opinion for Opzelura ® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 14:30:00 EEST | Press release
Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids (TCSs) and topical calcineurin inhibitors (TCIs) are inadequate or inappropriate. “AD is a chronic skin condition that can have a significant impact on daily life. The positive CHMP opinion for Opzelura marks meaningful progress toward bringing the first non-steroidal topical JAK treatment option to adults in Europe with moderate AD for whom standard topical therapies have failed,” said Lee Heeson, Executive Vice President and Head of Incyte International. “If approved by the European Commission, Opzelura could help address an important gap for patients who have limited treatment options when TCSs and TCIs are inadequate or inappropriate.” The positive CHMP o
Datroway ® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 14:00:00 EEST | Press release
Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the TROPION-Breast02phase 3 trial, which werepresented at the 2025 European Society for Medical Oncology Congress and published in Annals of Oncology. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In TROPION-Breast02, Datroway demonstrated a
DAYBU ® (trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 13:49:00 EEST | Press release
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating condition," said Catherine Owen Adams, Acadia’s Chief Executive Officer. “Our commitment is to make a meaningful difference in the lives of patients, caregivers, and the wider Rett com
HTEC Showcases Lakebase Branching at Databricks’ Data & AI Summit26.6.2026 12:18:00 EEST | Press release
HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. The Solution was developed in collaboration with a leading risk and compliance technology provider who serves financial institutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260626875859/en/ HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. Solving Critical Development Bottlenecks in Regulated Environments At the core of the collaboration was a shared challenge: how to enable modern data workflows in an envi
Stallergenes Greer Named One of Switzerland’s Best Managed Companies for 202626.6.2026 11:28:00 EEST | Press release
Stallergenes Greer, a global leader in allergy care, has been recognised for its overall business performance, company culture, and sustained growth by receiving the prestigious 2026 Switzerland’s Best Managed Companies award. The 2026 Best Managed Companies programme award winners are among Switzerland’s best private companies. The awards are derived from Deloitte’s global Best Managed Companies awards programme, an internationally recognised programme that evaluates businesses based on their leadership in the areas of strategy, culture and commitment, capabilities, innovation, governance and financial performance. Applicants are evaluated by an independent jury of experts. The evaluation of the Switzerland awards is based on more than 30 years of observed practice from the global awards programme that has been rolled out in 50+ countries worldwide. This recognition reflects Stallergenes Greer's consistent ability to deliver on its strategic vision while maintaining the operational di
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
